Suppr超能文献

南非不同服务提供模式和关键人群中常规艾滋病毒口服暴露前预防实施的成本与结果:一项回顾性队列研究

Costs and outcomes of routine HIV oral pre-exposure prophylaxis implementation across different service delivery models and key populations in South Africa: a retrospective cohort study.

作者信息

Hendrickson Cheryl, Hirasen Kamban, Mongwenyana Constance, Benade Mariet, Bothma Rutendo, Smith Chantal, Meyer Johan, Nichols Brooke E, Long Lawrence C

机构信息

Health Economics and Epidemiology Research Office, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Global Health, Amsterdam Institute for Global Health and Development, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.

Health Economics and Epidemiology Research Office, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

出版信息

Lancet HIV. 2025 Feb;12(2):e130-e142. doi: 10.1016/S2352-3018(24)00295-9.

Abstract

BACKGROUND

Despite several service delivery models that aim to improve uptake and persistence of pre-exposure prophylaxis (PrEP) in sub-Saharan Africa, the full costs of daily oral PrEP provision in routine care settings remain largely unknown. We aimed to evaluate outcomes and costs of daily oral PrEP delivery among key and priority populations at in-facility and community outreach programmes in South Africa.

METHODS

This retrospective cohort study was done at seven urban sites across South Africa with in-facility or community outreach PrEP service delivery models. We did top-down and bottom-up microcosting, from the provider perspective, of routine oral PrEP provision in programmes focusing on men who have sex with men (MSM), female sex workers, and adolescent girls and young women (aged 15-24 years) who initiated oral PrEP between March 12, 2018, and Aug 13, 2019. The primary outcome was PrEP in-hand at 6 months, defined as having sufficient PrEP drug dispensed at the last visit to have the drug available 6 months after PrEP initiation. A subset of enrolled participants with sufficient potential follow-up were included in a 12-month outcome analysis. We report the cost per client initiated on PrEP in 2021 US dollars.

FINDINGS

We enrolled 1281 people aged at least 15 years who initiated oral PrEP in either in-facility or community outreach programmes between March 12, 2018, and Aug 13, 2019. The proportion of participants with PrEP in-hand at 6 months varied from 41·8% (95% CI 31·9-52·2; 41 of 98 participants) at one MSM-focused clinic to 0% (0-6·7; 0 of 53 participants) in an MSM-focused outreach programme. Among 633 clients receiving oral PrEP with the potential for 12 months follow-up, 86 (13·6%) had PrEP in-hand at 12 months. The mean average 6-month costs per client initiating oral PrEP ranged from US$29 (95% CI 26-31) to $590 (488-692), with higher costs generally observed for in-facility programmes ($152, 140-164) than for outreach programmes ($84, 79-88). The mean average monthly cost per client with PrEP in-hand at 6 months ranged from $18 (15-21) to $160 (126-194).

INTERPRETATION

Costs and outcomes of daily oral PrEP provision across several populations and service delivery models in real-world settings show substantial variability. Policy makers should consider this variability when planning further scale-up of oral PrEP programmes in South Africa and the sub-Saharan Africa region to maximise opportunities to improve efficiency based on local context.

FUNDING

The US President's Emergency Plan for AIDS Relief, the US Agency for International Development, and the National Institutes of Health.

摘要

背景

尽管有多种服务提供模式旨在提高撒哈拉以南非洲地区暴露前预防(PrEP)的接受率和持续率,但在常规护理环境中每日口服PrEP的全部成本仍基本未知。我们旨在评估南非医疗机构和社区外展项目中重点人群和优先人群每日口服PrEP的效果和成本。

方法

这项回顾性队列研究在南非七个城市地点进行,采用医疗机构或社区外展PrEP服务提供模式。我们从提供者的角度,对2018年3月12日至2019年8月13日期间开始口服PrEP的男男性行为者(MSM)、女性性工作者以及青少年女孩和年轻女性(15 - 24岁)项目中的常规口服PrEP进行了自上而下和自下而上的微观成本核算。主要结局是6个月时手中有PrEP,定义为在最后一次就诊时发放了足够的PrEP药物,以便在开始PrEP后6个月有药可用。一部分有足够潜在随访的登记参与者被纳入12个月结局分析。我们报告以2021年美元计算的每位开始接受PrEP的客户的成本。

结果

我们纳入了1281名年龄至少15岁的人,他们在2018年3月12日至2019年8月13日期间在医疗机构或社区外展项目中开始口服PrEP。6个月时手中有PrEP的参与者比例在一个以MSM为重点的诊所中为41.8%(95%CI 31.9 - 52.2;98名参与者中的41名),在一个以MSM为重点的外展项目中为0%(0 - 6.7;53名参与者中的0名)。在633名接受口服PrEP且有可能进行12个月随访的客户中,86名(13.6%)在12个月时手中有PrEP。每位开始口服PrEP的客户6个月的平均成本从29美元(95%CI 26 - 31)到590美元(488 - 692)不等,医疗机构项目(152美元,140 - 164)的成本通常高于外展项目(84美元,79 - 88)。6个月时手中有PrEP的每位客户的平均每月成本从18美元(15 - 21)到160美元(126 - 194)不等。

解读

在现实环境中,不同人群和服务提供模式下每日口服PrEP的成本和效果存在很大差异。政策制定者在规划南非和撒哈拉以南非洲地区进一步扩大口服PrEP项目时应考虑这种差异,以便根据当地情况最大限度地提高效率。

资金来源

美国总统艾滋病紧急救援计划、美国国际开发署和美国国立卫生研究院。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验